nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—stomach cancer	0.507	1	CbGaD
Gadobenate Dimeglumine—ALB—Irinotecan—stomach cancer	0.106	0.402	CbGbCtD
Gadobenate Dimeglumine—ALB—Fluorouracil—stomach cancer	0.101	0.386	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—stomach cancer	0.0559	0.213	CbGbCtD
Gadobenate Dimeglumine—Hyperhidrosis—Capecitabine—stomach cancer	0.000126	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—stomach cancer	0.000126	0.000545	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—stomach cancer	0.000125	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—stomach cancer	0.000125	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—stomach cancer	0.000125	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—stomach cancer	0.000125	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—stomach cancer	0.000124	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Irinotecan—stomach cancer	0.000123	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—stomach cancer	0.000123	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—stomach cancer	0.000123	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—stomach cancer	0.000123	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—stomach cancer	0.000123	0.000532	CcSEcCtD
Gadobenate Dimeglumine—Rash—Irinotecan—stomach cancer	0.000122	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Irinotecan—stomach cancer	0.000122	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000122	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—stomach cancer	0.000122	0.00053	CcSEcCtD
Gadobenate Dimeglumine—Headache—Irinotecan—stomach cancer	0.000122	0.000528	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Capecitabine—stomach cancer	0.000121	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—stomach cancer	0.000121	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—stomach cancer	0.00012	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—stomach cancer	0.00012	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—stomach cancer	0.000119	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—stomach cancer	0.000119	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—stomach cancer	0.000119	0.000517	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—stomach cancer	0.000119	0.000515	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—stomach cancer	0.000119	0.000514	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—stomach cancer	0.000119	0.000514	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000118	0.000514	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—stomach cancer	0.000118	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—stomach cancer	0.000118	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—stomach cancer	0.000118	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—stomach cancer	0.000118	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—stomach cancer	0.000118	0.000513	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000117	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—stomach cancer	0.000117	0.000509	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—stomach cancer	0.000117	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Capecitabine—stomach cancer	0.000117	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—stomach cancer	0.000116	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000116	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—stomach cancer	0.000116	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—stomach cancer	0.000116	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000116	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000116	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Capecitabine—stomach cancer	0.000116	0.000503	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—stomach cancer	0.000116	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—stomach cancer	0.000116	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—stomach cancer	0.000116	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irinotecan—stomach cancer	0.000115	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—stomach cancer	0.000115	0.000499	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—stomach cancer	0.000115	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—stomach cancer	0.000115	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—stomach cancer	0.000115	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—stomach cancer	0.000115	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Capecitabine—stomach cancer	0.000114	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—stomach cancer	0.000114	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—stomach cancer	0.000114	0.000494	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—stomach cancer	0.000114	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000112	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Capecitabine—stomach cancer	0.000112	0.000486	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—stomach cancer	0.000112	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Pain—Capecitabine—stomach cancer	0.000111	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Capecitabine—stomach cancer	0.000111	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—stomach cancer	0.000111	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—stomach cancer	0.000111	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—stomach cancer	0.000111	0.00048	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—stomach cancer	0.00011	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—stomach cancer	0.00011	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—stomach cancer	0.00011	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—stomach cancer	0.00011	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00011	0.000476	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—stomach cancer	0.00011	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—stomach cancer	0.000109	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—stomach cancer	0.000109	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—stomach cancer	0.000109	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—stomach cancer	0.000107	0.000466	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Capecitabine—stomach cancer	0.000107	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—stomach cancer	0.000107	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—stomach cancer	0.000107	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—stomach cancer	0.000107	0.000463	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—stomach cancer	0.000106	0.000462	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000106	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000106	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—stomach cancer	0.000106	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—stomach cancer	0.000106	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—stomach cancer	0.000106	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—stomach cancer	0.000106	0.000459	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—stomach cancer	0.000105	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—stomach cancer	0.000103	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—stomach cancer	0.000103	0.000448	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Capecitabine—stomach cancer	0.000103	0.000448	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—stomach cancer	0.000103	0.000447	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Capecitabine—stomach cancer	0.000103	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Capecitabine—stomach cancer	0.000103	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—stomach cancer	0.000103	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—stomach cancer	0.000103	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—stomach cancer	0.000103	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—stomach cancer	0.000101	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—stomach cancer	0.000101	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—stomach cancer	0.000101	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—stomach cancer	0.000101	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.0001	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—stomach cancer	0.0001	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—stomach cancer	9.97e-05	0.000433	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—stomach cancer	9.95e-05	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—stomach cancer	9.93e-05	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—stomach cancer	9.93e-05	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—stomach cancer	9.89e-05	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—stomach cancer	9.87e-05	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—stomach cancer	9.8e-05	0.000425	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—stomach cancer	9.75e-05	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—stomach cancer	9.75e-05	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—stomach cancer	9.68e-05	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—stomach cancer	9.67e-05	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—stomach cancer	9.63e-05	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—stomach cancer	9.61e-05	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—stomach cancer	9.58e-05	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Capecitabine—stomach cancer	9.57e-05	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—stomach cancer	9.52e-05	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—stomach cancer	9.5e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—stomach cancer	9.49e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—stomach cancer	9.49e-05	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—stomach cancer	9.44e-05	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—stomach cancer	9.44e-05	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—stomach cancer	9.44e-05	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—stomach cancer	9.41e-05	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—stomach cancer	9.4e-05	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	9.38e-05	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—stomach cancer	9.35e-05	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—stomach cancer	9.33e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Capecitabine—stomach cancer	9.32e-05	0.000405	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—stomach cancer	9.26e-05	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—stomach cancer	9.24e-05	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—stomach cancer	9.2e-05	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Capecitabine—stomach cancer	9.19e-05	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—stomach cancer	9.19e-05	0.000399	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—stomach cancer	9.18e-05	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—stomach cancer	9.13e-05	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—stomach cancer	9.07e-05	0.000394	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—stomach cancer	9.05e-05	0.000393	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—stomach cancer	9.04e-05	0.000392	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—stomach cancer	9.02e-05	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—stomach cancer	8.99e-05	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—stomach cancer	8.96e-05	0.000389	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—stomach cancer	8.91e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Capecitabine—stomach cancer	8.89e-05	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—stomach cancer	8.88e-05	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—stomach cancer	8.88e-05	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—stomach cancer	8.86e-05	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—stomach cancer	8.84e-05	0.000383	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—stomach cancer	8.81e-05	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—stomach cancer	8.79e-05	0.000382	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—stomach cancer	8.75e-05	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—stomach cancer	8.74e-05	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—stomach cancer	8.74e-05	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—stomach cancer	8.74e-05	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—stomach cancer	8.71e-05	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—stomach cancer	8.69e-05	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	8.68e-05	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—stomach cancer	8.63e-05	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—stomach cancer	8.62e-05	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—stomach cancer	8.6e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Capecitabine—stomach cancer	8.59e-05	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—stomach cancer	8.55e-05	0.000371	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—stomach cancer	8.53e-05	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—stomach cancer	8.52e-05	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—stomach cancer	8.46e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—stomach cancer	8.46e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—stomach cancer	8.45e-05	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—stomach cancer	8.45e-05	0.000366	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—stomach cancer	8.41e-05	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—stomach cancer	8.38e-05	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—stomach cancer	8.35e-05	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—stomach cancer	8.34e-05	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—stomach cancer	8.32e-05	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—stomach cancer	8.27e-05	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Capecitabine—stomach cancer	8.26e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—stomach cancer	8.25e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—stomach cancer	8.24e-05	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—stomach cancer	8.21e-05	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Rash—Capecitabine—stomach cancer	8.19e-05	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Capecitabine—stomach cancer	8.19e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—stomach cancer	8.18e-05	0.000355	CcSEcCtD
Gadobenate Dimeglumine—Headache—Capecitabine—stomach cancer	8.14e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—stomach cancer	8.14e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—stomach cancer	8.13e-05	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—stomach cancer	8.1e-05	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—stomach cancer	8.07e-05	0.00035	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—stomach cancer	8.05e-05	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—stomach cancer	7.97e-05	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—stomach cancer	7.97e-05	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—stomach cancer	7.97e-05	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—stomach cancer	7.91e-05	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—stomach cancer	7.83e-05	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—stomach cancer	7.82e-05	0.000339	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—stomach cancer	7.8e-05	0.000339	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—stomach cancer	7.74e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—stomach cancer	7.74e-05	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Capecitabine—stomach cancer	7.72e-05	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—stomach cancer	7.68e-05	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—stomach cancer	7.65e-05	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—stomach cancer	7.65e-05	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	7.63e-05	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—stomach cancer	7.52e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—stomach cancer	7.47e-05	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—stomach cancer	7.46e-05	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—stomach cancer	7.45e-05	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—stomach cancer	7.4e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—stomach cancer	7.37e-05	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—stomach cancer	7.23e-05	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—stomach cancer	7.22e-05	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—stomach cancer	7.19e-05	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—stomach cancer	7.16e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—stomach cancer	7.16e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—stomach cancer	7.16e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—stomach cancer	7.16e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—stomach cancer	7.13e-05	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—stomach cancer	6.94e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—stomach cancer	6.9e-05	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—stomach cancer	6.85e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—stomach cancer	6.84e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—stomach cancer	6.67e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—stomach cancer	6.65e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—stomach cancer	6.62e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—stomach cancer	6.62e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—stomach cancer	6.62e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—stomach cancer	6.5e-05	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—stomach cancer	6.4e-05	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—stomach cancer	6.4e-05	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—stomach cancer	6.19e-05	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—stomach cancer	6.17e-05	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—stomach cancer	6.15e-05	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—stomach cancer	6.1e-05	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—stomach cancer	6.09e-05	0.000264	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—stomach cancer	6.06e-05	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—stomach cancer	6.01e-05	0.000261	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—stomach cancer	5.99e-05	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—stomach cancer	5.93e-05	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—stomach cancer	5.76e-05	0.00025	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—stomach cancer	5.75e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—stomach cancer	5.73e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—stomach cancer	5.71e-05	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—stomach cancer	5.7e-05	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—stomach cancer	5.67e-05	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—stomach cancer	5.54e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—stomach cancer	5.38e-05	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—stomach cancer	5.33e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—stomach cancer	5.28e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—stomach cancer	5.28e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—stomach cancer	5.25e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—stomach cancer	4.98e-05	0.000216	CcSEcCtD
